TREACE MED CONCEPTS INC shareholders Q2 2024

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 125 filers reported holding TREACE MED CONCEPTS INC in Q2 2024. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

TREACE MED CONCEPTS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Kent Lake Capital LLC 750,000$4,987,5002.25%
Soleus Capital Management, L.P. 2,365,648$15,731,5591.39%
GAGNON SECURITIES LLC 483,581$3,215,8140.72%
ARMISTICE CAPITAL, LLC 5,360,000$35,644,0000.45%
Divisadero Street Capital Management, LP 114,400$760,7600.12%
GSA CAPITAL PARTNERS LLP 191,427$1,2730.09%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 212,976$1,416,2900.09%
KORNITZER CAPITAL MANAGEMENT INC /KS 526,918$3,504,0050.07%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 3,681,718$24,483,4250.06%
Lighthouse Investment Partners, LLC 167,500$1,113,8750.04%
ALGERT GLOBAL LLC 162,536$1,0810.04%
Y-Intercept (Hong Kong) Ltd 96,317$640,5080.04%
Bensler, LLC 35,511$236,1480.03%
Accredited Investors Inc. 69,000$458,8500.03%
CIBC Private Wealth Group LLC 1,928,016$12,840,5870.02%
Jump Financial, LLC 169,200$1,125,1800.02%
PDT Partners, LLC 32,714$217,5480.02%
Atom Investors LP 29,066$193,2890.02%
Bleakley Financial Group, LLC 80,936$538,2240.02%
XTX Topco Ltd 24,104$160,2920.01%
External links

This page lists TREACE MED CONCEPTS INC's shareholders in Q2 2024. To view TREACE MED CONCEPTS INC's shareholder history, click here.